From: Using neural networks to support high-quality evidence mapping
Class | Precision | Recall | F1 |
---|---|---|---|
Diagnosis | 0.71 (0.06) | 0.61 (0.08) | 0.66 (0.07) |
Etiology | 0.69 (0.04) | 0.52 (0.08) | 0.59 (0.04) |
Experiences and perceptions; consequences; social, political, economic aspects | 0.80 (0.10) | 0.38 (0.07) | 0.51 (0.07) |
Infection prevention and control | 0.72 (0.23) | 0.11 (0.02) | 0.18 (0.03) |
Interventions targeted at system level | 0.23 (0.27) | 0.08 (0.12) | 0.11 (0.17) |
Interventions to treat the infected patient | 0.73 (0.06) | 0.39 (0.04) | 0.51 (0.04) |
Prevalence and incidence | 0.63 (0.07) | 0.28 (0.03) | 0.39 (0.04) |
Prognosis | 0.73 (0.05) | 0.61 (0.04) | 0.66 (0.02) |